ABL1, ABL proto-oncogene 1, non-receptor tyrosine kinase, 25
N. diseases: 395; N. variants: 37
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.672 | 0.160 | 9 | 130872896 | missense variant | C/T | snv |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.724 | 0.440 | 9 | 130872961 | missense variant | G/A | snv |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.672 | 0.160 | 9 | 130872896 | missense variant | C/T | snv |
|
Neoplasms | 0.100 | 1.000 | 18 | 2004 | 2018 | ||||||||
|
0.672 | 0.160 | 9 | 130872896 | missense variant | C/T | snv |
|
Neoplasms | 0.100 | 1.000 | 13 | 2009 | 2018 | ||||||||
|
0.672 | 0.160 | 9 | 130872896 | missense variant | C/T | snv |
|
Neoplasms | 0.060 | 1.000 | 6 | 2009 | 2020 | ||||||||
|
0.827 | 0.120 | 9 | 130862976 | missense variant | G/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||||
|
0.851 | 0.080 | 9 | 130873027 | missense variant | T/A;C;G | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.851 | 0.080 | 9 | 130873027 | missense variant | T/A;C;G | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.672 | 0.160 | 9 | 130872896 | missense variant | C/T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||||
|
0.672 | 0.160 | 9 | 130872896 | missense variant | C/T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.851 | 0.120 | 9 | 130862970 | missense variant | T/C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.851 | 0.120 | 9 | 130862970 | missense variant | T/C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.827 | 0.120 | 9 | 130862919 | missense variant | G/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||||
|
1.000 | 0.040 | 9 | 130714356 | missense variant | A/G | snv | 4.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.672 | 0.160 | 9 | 130872896 | missense variant | C/T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.800 | 0.943 | 105 | 2001 | 2020 | ||||||||
|
0.827 | 0.120 | 9 | 130862976 | missense variant | G/A | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.730 | 1.000 | 18 | 2001 | 2014 | ||||||||
|
0.851 | 0.120 | 9 | 130862970 | missense variant | T/C | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 16 | 2002 | 2014 | ||||||||
|
1.000 | 0.080 | 9 | 130873004 | missense variant | T/C | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.710 | 1.000 | 15 | 2002 | 2014 | ||||||||
|
0.851 | 0.080 | 9 | 130873027 | missense variant | T/A;C;G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.740 | 1.000 | 14 | 2003 | 2014 | ||||||||
|
0.851 | 0.160 | 9 | 130872903 | missense variant | C/A;G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.710 | 1.000 | 12 | 2002 | 2014 | ||||||||
|
1.000 | 0.080 | 9 | 130862977 | missense variant | A/T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 10 | 2001 | 2014 | ||||||||
|
1.000 | 0.080 | 9 | 130862943 | missense variant | A/G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.710 | 1.000 | 10 | 2002 | 2014 | ||||||||
|
1.000 | 0.080 | 9 | 130873016 | missense variant | A/G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 8 | 2002 | 2014 | ||||||||
|
1.000 | 0.080 | 9 | 130862962 | missense variant | G/A | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 8 | 2002 | 2014 | ||||||||
|
0.925 | 0.080 | 9 | 130874969 | missense variant | A/G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.710 | 1.000 | 8 | 2002 | 2016 |